SuperworthAcurx Pharmaceuticals shares outstanding ACXP
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 4.3M
- On a year earlier
- +257.9%
- more shares
Acurx Pharmaceuticals had 4.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 257.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 2.2M | +155% |
| FY2024 | 846.2K | +22% |
| FY2023 | 691.4K | +19% |
| FY2022 | 580.1K | +14% |
| FY2021 | 508K | +53% |
| FY2020 | 332.4K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 4.3M | +258% | |
| Q1 FY26 | 2.7M | +171% | |
| Q4 FY25 | 2.2M | +155% | |
| Q3 FY25 | 1.6M | +99% | |
| Q2 FY25 | 1.2M | +50% | |
| Q1 FY25 | 1M | +30% | |
| Q4 FY24 | 846.2K | +22% | |
| Q3 FY24 | 818.2K | +26% | |
| Q2 FY24 | 791.2K | +30% | |
| Q1 FY24 | 773.6K | +33% | |
| Q4 FY23 | 691.4K | +19% | |
| Q3 FY23 | 650.3K | +17% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Acurx Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.